The cost-effectiveness of screening for chronic hepatitis B infection in the United States.
about
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesHepatitis B among Asian Americans: Prevalence, progress, and prospects for controlThe etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.Markov modeling in hepatitis B screening and linkage to careHepatitis B virus: where do we stand and what is the next step for eradication?Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge.Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.A comprehensive screening and treatment model for reducing disparities in hepatitis B.Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral loadTesting and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012-2014.Early Identification and Linkage to Care of Foreign-Born People with Chronic Hepatitis B Virus Infection, Multnomah County, Oregon, 2012-2014Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.Disease burden of chronic hepatitis B among immigrants in Canada.Monetary conversion factors for economic evaluations of substance use disorders.Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening.Hepatitis B in patients with hematological diseases: An update.Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England.Economic analysis of hepatitis B screening and treatment.Should chronic hepatitis B be treated as early as possible?Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.The patient, the doctor, and the system: underdiagnosis and undertreatment of hepatitis B.Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014.A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital.Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010.Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries.High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance.Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in BrazilThe Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
P2860
Q26774500-546D7B40-4607-48C2-AA6C-EC4B3AE55638Q28088546-B44F2549-C164-47A0-9A44-039BE271E71BQ30457852-90894580-0859-444D-BBB8-142B974A56AAQ30861975-91AC8CFA-3139-4F4B-94A1-4E26BFBB30E0Q33706787-F43EBD44-1D63-4994-ACA1-2A11EA15DFC1Q33958764-4DD6226B-6720-40D6-A724-5B923E720F47Q34137291-D3E85D63-3BC4-4E69-A2D5-7FEA791EF671Q34277478-26CA3A9B-9FA5-4858-B146-5A49A8BDA20CQ34408236-42FCB560-158E-4C0E-BE4C-D364E5BEA36AQ34461033-E6FF3E7B-A3A6-4AF6-BB58-CE011C6106CEQ34677180-E92C50E3-2C7D-4A64-B887-0207AD6F594CQ35036504-1886CD2E-8341-4E52-9F65-17F53C3979FFQ35905848-8AE01829-7D88-4B9A-8839-151A71D6C086Q36250930-039918BD-E167-48EF-A063-424933269705Q36379986-F5308CCC-65E8-4581-BD2C-5C313627EFF0Q36858844-C5620642-C668-4B65-9578-E060C6F86A11Q36858906-64092562-ED1C-44BE-9B85-271DA2941F35Q37037308-4EC5CC71-AE96-487F-AB16-2E8203217169Q37066397-B503BDBA-A0E4-4797-AB3F-13114CE4EDF0Q38605382-7AF0E282-4F52-4F87-A8FF-97D391578FC6Q38631865-CDA462E5-4B8B-460B-8BB0-52462458100CQ38797618-0654D797-0100-4DBB-9A5A-AA8F16BD88F1Q41690596-4AFA5142-9DA1-410B-A270-9DD1BA60ADC2Q42279465-329B27FD-8923-4E31-92F1-4AF392F03B09Q42735976-1FE7572B-1E24-4565-83BE-9CD3F43EEAECQ43411652-B4ADAA5C-FB39-49C2-ACD1-EAE2DE43952AQ44464330-6A65A3BA-7A75-454D-B898-3DDC6A3C485FQ45014096-EF9263EE-139E-4EDC-974E-AC66A8CD82B9Q45323572-404C7244-7BD4-4E14-90E1-C745A3723A01Q45323738-FFADDC50-9382-430B-A2FB-0F8CAC82543DQ46169320-8E6169AA-0BC2-4898-9D36-2FC657314677Q47103647-07385DB4-263D-4055-9FAD-893CDCA0A52CQ53697494-C781D1C6-2671-47DE-837A-3E6400603D53Q58759982-48677C6A-94A1-4100-8BFD-6C9FC64FAEE4Q58773342-D3725C08-BA9B-4F7E-AF4D-C5E8020D83FC
P2860
The cost-effectiveness of screening for chronic hepatitis B infection in the United States.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The cost-effectiveness of scre ...... nfection in the United States.
@ast
The cost-effectiveness of scre ...... nfection in the United States.
@en
The cost-effectiveness of scre ...... nfection in the United States.
@nl
type
label
The cost-effectiveness of scre ...... nfection in the United States.
@ast
The cost-effectiveness of scre ...... nfection in the United States.
@en
The cost-effectiveness of scre ...... nfection in the United States.
@nl
prefLabel
The cost-effectiveness of scre ...... nfection in the United States.
@ast
The cost-effectiveness of scre ...... nfection in the United States.
@en
The cost-effectiveness of scre ...... nfection in the United States.
@nl
P2093
P2860
P356
P1476
The cost-effectiveness of scre ...... nfection in the United States.
@en
P2093
Kenneth E Sherman
Mark H Eckman
Tiffany E Kaiser
P2860
P304
P356
10.1093/CID/CIR199
P407
P577
2011-05-02T00:00:00Z